|
⚲
|
| Keyboard |
| Taylor John Clayton
✚
|
|
|---|---|
| CIK # | 0001947029 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001947029] | |
| 4 | [0001947029] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Idera Pharmaceuticals Inc | |
| Taylor John Clayton |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Idera Pharmaceuticals Inc ACGN
Stock Options (Right to Buy) · derivative
|
2023-01-20 | Grant | 74,500 | $0.00 | |
|
Idera Pharmaceuticals Inc ACGN
Common Stock
|
2023-01-17 | Option exercise | 1,341,764 | ||
|
Idera Pharmaceuticals Inc ACGN
Series Z Convertible Preferred Stock · derivative
|
2023-01-17 | Option exercise | 22,810 | ||
|
Idera Pharmaceuticals Inc IDRA
Common Stock, par value $0.001
|
2022-09-28 | Grant | 2,171,214 | ||
|
Idera Pharmaceuticals Inc IDRA
Series Z Convertible Preferred Stock · derivative
|
2022-09-28 | Grant | 22,810 |